Pharmaceutical Product Development News and Activities

Pharmaceutical Product Development is owned by Thermo Fisher Scientific.

Thermo Fisher Scientific is one of the...

• Forbes Global 2000 (#148);
• Fortune 500 (#101);
• Global Fortune 500 (#359);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Thermo Fisher Scientific is a company listed under the stock ticker TMO (US).

Thermo Fisher Scientific has a direct presence in 6 countries.

Thermo Fisher Scientific has 13 subsidiaries including BioDuro-Sundia, Clario and CorEvitas.

They are in:

• Medical Equipment36%
• Biotechnology21%
• Other43%

Acquisition, funding and merger involving Thermo Fisher Scientific.

• Thermo Fisher Scientific has acquired Clario (posted on March 24 2026).
• Thermo Fisher Scientific has acquired Olink Holding (posted on July 11 2024).

View the org chart displaying its 41 main executives

Most searched biographies at Pharmaceutical Product Development

• Dirk Reitsma, Senior Vice President, Global Product Development
• Matthew O'connell, Senior Business Manager
• Keri Henderson, Vice President and Chief Technology Officer, Clini...

Popular executive movements at Pharmaceutical Product Development

• Travis Cox, Director, Information Technology, has left the company  (posted on June 2 2026).

Popular executive movements at Thermo Fisher Scientific

• Gregg Kunes, Vice President, Digital Commerce Platforms, has left the company  (posted on March 27 2026).
• Katy Preston who was Vice President Global Human Resources, Immunodiagnostics, becomes Vice President Human Resources, Lab Equipment  (posted on October 21 2025).
• Purcell Claribel has joined the company as Vice President, Global Microbiology Sales  (posted on September 26 2025).

Create your alert
to follow the executive moves at Pharmaceutical Product Development.

Thermo Fisher Scientific has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Pharmaceutical Product Development

• PPD to Open Multipurpose Clinical Research Laboratory in Suzhou, China | PPD
• PPD Announces Third Quarter 2020 Earnings Conference Call | PPD
• PPD Recognized at Vaccine Industry Excellence Awards | PPD
• PPD Achieves ISO/IEC 27001:2013 Certification for Information Security Management | PPD
• News Releases | PPD

Social media about Pharmaceutical Product Development

• Pharmaceutical Product Development on Wikipedia, Google News & Yahoo Finance
• Pharmaceutical Product Development on LinkedIn, X (Twitter) & YouTube